Ann: Collaboration with Little Green Pharma Ltd, page-111

'that avoided dilution to the company with share issues to pay for the research'

Ummmm, I'd call over 1.8 billion shares on issue, heading towards 20 years and still in the R&D/testing/soft launch phase and not very much at all official published data; as a complete contradiction to your above statement. History and facts typically don't lie, but then again maybe they do, as it's not like OBJ Shareholders have ever been given all the facts...is it .

And Bassman, ignore the haters and enjoy those well-earned lightbulbs!